Table 5.
Histologically verified high-grade lesionsa among long-term non-attenders by intervention arm.
| Control, n (%) | Opt-in, n (%) | Send-to-all, n (%) | |||||
|---|---|---|---|---|---|---|---|
| Clin-sample | Self-sample | Clin-sample | Total | Self-sample | Clin-sample | Total | |
| Invited | 1892 | 1897 | 1878 | ||||
| Screened | 90 (4.8) | 250 (13.2) | 73 (3.8) | 323 (17.0) | 445 (23.7) | 75 (4.0) | 520 (27.7) |
| Had histology resultb | 3 (0.2) | 15 (0.8) | 5 (0.3) | 20 (1.1) | 32 (1.7) | 6 (0.3) | 38 (2.0) |
| Had histology resultc | 3 (3.3) | 15 (6.0) | 5 (6.8) | 20 (6.2) | 32 (7.2) | 6 (8.0) | 38 (7.3) |
| CIN2 + detectedb | 1 (0.1) | 9 (0.5) | 3 (0.2) | 12 (0.6) | 17 (0.9) | 3 (0.2) | 20 (1.1) |
| CIN2 + detectedc | 1 (1.1) | 9 (3.6) | 3 (4.1) | 12 (3.7) | 17 (3.8) | 3 (4.0) | 20 (3.8) |
| CIN3 + detectedb | 1 (0.1) | 7 (0.4) | 3 (0.2) | 10 (0.5) | 17 (0.9) | 3 (0.2) | 20 (1.1) |
| CIN3 + detectedc | 1 (1.1) | 7 (2.8) | 3 (4.1) | 10 (3.1) | 17 (3.8) | 3 (4.0) | 20 (3.8) |
| Cervical cancer detected | 0 (0.0) | 3 (1.2) | 1 (1.4) | 4 (1.2) | 6 (1.3) | 1 (1.3) | 7 (1.3) |
aCIN2, CIN3, ACIS or cancer.
bPer cent of women invited.
cPer cent of women screened.